Picha; Kristen

Patent Applications and Registrations

Patent applications and USPTO patent grants for Picha; Kristen.The latest application filed is for "egfr and c-met fibronectin type iii domain binding molecules".

Company Profile

1.15.26

Picha; Kristen - Malvern PA
Picha; Kristen - Spring House PA
Picha; Kristen - Radnor PA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
EGFR and C-Met Fibronectin Type III Domain Binding Molecules App 20210206825 - Anderson; Mark ; et al.	2021-07-08
EGFR and c-Met fibronectin type III domain binding molecules Grant 10,954,284 - Anderson , et al. March 23, 2	2021-03-23
Cysteine Engineered Fibronectin Type Iii Domain Binding Molecules App 20200325210 - Anderson; Mark ; et al.	2020-10-15
Cysteine engineered fibronectin type III domain binding molecules Grant 10,662,235 - Anderson , et al.	2020-05-26
Cysteine Engineered Fibronectin Type III Domain Binding Molecules App 20170362301 - Anderson; Mark ; et al.	2017-12-21
EGFR and C-Met Fibronectin Type III Domain Binding Molecules App 20170305997 - Anderson; Mark ; et al.	2017-10-26
EGFR and C-Met fibronectin type III domain binding molecules Grant 9,725,497 - Anderson , et al. August 8, 2	2017-08-08
EGFR and c-Met fibronectin type III domain binding molecules Grant 9,695,228 - Mark , et al. July 4, 2	2017-07-04
Antibodies binding human collagen II Grant 8,906,649 - Kehoe , et al. December 9, 2	2014-12-09
Anti-GLP-1R antibodies and their uses Grant 8,883,447 - O'Neil , et al. November 11, 2	2014-11-11
Antibodies binding human collagen II App 20140220634 - Kehoe; John ; et al.	2014-08-07
Anti-GLP-1R Antibodies and Their Uses App 20140162316 - O'Neil; Karyn ; et al.	2014-06-12
Egfr And C-met Fibronectin Type Iii Domain Binding Molecules App 20140155325 - Mark; Anderson ; et al.	2014-06-05
Egfr And C-met Fibronectin Type Iii Domain Binding Molecules App 20140155326 - Mark; Anderson ; et al.	2014-06-05
Antibodies binding human collagen II Grant 8,394,378 - Kehoe , et al. March 12, 2	2013-03-12
Anti-GLP-1R antibodies and their uses Grant 8,389,689 - O'Neil , et al. March 5, 2	2013-03-05
Toll Like Receptor 3 Antagonists, Methods and Uses App 20120189643 - Carton; Jill M. ; et al.	2012-07-26
Antibodies Binding Human Collagen II App 20120108795 - Kehoe; John ; et al.	2012-05-03
Toll like receptor 3 antagonists, methods and uses Grant 8,153,583 - Carton , et al. April 10, 2	2012-04-10
Human Epo Mimetic Hinge Core Mimetibodies, Compositions, Methods And Uses For Preventing Or Treating Glucose Intolerance Related Conditions Or Renal Disease Associated Anemia App 20120082669 - James; Ian E. ; et al.	2012-04-05
Pharmaceutical composition comprising a human GLP-1 mimetibody Grant 8,071,103 - O'Neil , et al. December 6, 2	2011-12-06
sRAGE mimetibody, compositions, methods and uses Grant 8,043,616 - Anderson , et al. October 25, 2	2011-10-25
Anti-GLP-1R Antibodies and Their Uses App 20110098443 - O'Neil; Karyn ; et al.	2011-04-28
Resistin Antagonists And Their Use App 20110071277 - Blake; Simon ; et al.	2011-03-24
Method for treating insulin sensitivity by long-acting GLP-1 receptor mimetibody agonists Grant 7,833,531 - O'Neil , et al. November 16, 2	2010-11-16
GLP-2 mimetibodies, polypeptides, compositions, methods and uses Grant 7,812,121 - Baker , et al. October 12, 2	2010-10-12
Human Epo Receptor Agonists, Compositions, Methods And Uses For Preventing Or Treating Glucose Intolerance Related Conditions App 20100183592 - James; Ian E. ; et al.	2010-07-22
Human Epo Mimetic Hinge Core Mimetibodies, Compositions, Methods And Uses For Preventing Or Treating Glucose Intolerance Related Conditions On Renal Disease Associated Anemia App 20100034819 - James; Ian E. ; et al.	2010-02-11
Human Glp-1 Mimetibodies, Compositions, Methods And Uses App 20090325873 - O'Neil; Karyn T. ; et al.	2009-12-31
Resistin Antagonists And Their Use App 20090162375 - Blake; Simon ; et al.	2009-06-25
GLP-2 Mimetibodies, Polypeptides, Compositions, Methods and Uses App 20090117104 - Baker; Audrey E. ; et al.	2009-05-07
Use Of Long-acting Glp-1 Receptor Agonists To Improve Insulin Sensitivity And Lipid Profiles App 20090098108 - O'Neil; Karyn T. ; et al.	2009-04-16
sRAGE Mimetibody, Compositions, Methods and Uses App 20090098122 - Anderson; Glenn Mark ; et al.	2009-04-16
Human Glp-1 Mimetibodies, Compositions, Methods And Uses App 20080044411 - O'NEIL; Karyn T. ; et al.	2008-02-21
GLP-2 Mimetibodies, Polypeptides, Compositions, Methods and Uses App 20070212355 - Baker; Audrey E. ; et al.	2007-09-13
Human GLP-1 mimetibodies, compositions, methods and uses App 20070135338 - O'Neil; Karyn ; et al.	2007-06-14
GLP-1 agonists, compositions, methods and uses App 20070128193 - O'Neil; Karyn T. ; et al.	2007-06-07
Toll like receptor 3 antagonists, methods and uses App 20060115475 - Carton; Jill M. ; et al.	2006-06-01
sRAGE mimetibody, compositions, methods and uses App 20060084145 - Anderson; Glenn Mark ; et al.	2006-04-20

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.